At Sweeney Scharkey, we deliver the personalized and superior guidance our clients expect in a global and fast-paced environment. We are a team of high-performing, exceptionally talented individuals who relentlessly pursue excellence in every matter we accept. We combine the creativity, expertise, and experience of our entire firm to confront our clients’ most complex and sensitive matters and achieve their goals.
Noteworthy
Analysis & Outlook
Delaware court concludes Section 141(a) of the DCGL vests board of directors with management authority, market practice notwithstanding.
Delaware court dismisses claims that AstraZeneca UK, which holds a 26.7% stake in Viela Bio, Inc., breached fiduciary duties in $3 billion sale.








